Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malignant Lymphoma

Free Subscription 20.10.2025 1 Am J Hematol 1 Br J Dermatol 2 Br J Haematol 1 Haematologica 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 5 Leuk Lymphoma 1 Neurologia (Engl Ed) 1 Oncology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. 
   Abstracts from the 2025 Lymphoma Leukemia and Myeloma Congress October 14-17, 2025.
   Am J Hematol. 2025;100 Suppl 5:S3-S80.
   PubMed        
   
   

   
   Br J Dermatol

2. LIU Z, Zhang Y, Wang K, Xie F, et al
   Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.
   Br J Dermatol. 2025 Jun 4:ljaf212. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Br J Haematol

3. SALVINO MA, Luisi FAV, Pianovski MA, Fagioli F, et al
   A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.
   Br J Haematol. 2025 Oct 14. doi: 10.1111/bjh.70207.
   PubMed        
   
   
4. VONBERG FW, Rice-Wilson D, Malik I, Keddie S, et al
   Transient imaging changes accompany 'spinal ICANS' following CAR T-cell therapy for large B-cell lymphoma in adults.
   Br J Haematol. 2025 Oct 13. doi: 10.1111/bjh.70206.
   PubMed        
   
   

   
   Haematologica

5. HARDY NM, Yared JA, Luetkens T, Ahmad H, et al
   CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma.
   Haematologica. 2025 Oct 16. doi: 10.3324/haematol.2025.288856.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

6. SAIFI O, Lester SC, Laack N, Rule WG, et al
   The Role of Radiation Therapy in the Management of Gray Zone Lymphoma.
   Int J Radiat Oncol Biol Phys. 2025;123:947-954.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

7. NEELAPU SS, Chavez JC, Sehgal AR, Epperla N, et al
   Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.
   J Clin Oncol. 2025 Oct 16:JCO2500668. doi: 10.1200/JCO-25-00668.
   PubMed         Abstract available
   
   

   
   Leuk Lymphoma

8. CHAUDHRY AL, Chevez-Barrios P, Strati P
   Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma.
   Leuk Lymphoma. 2025 Jul 26:1-4. doi: 10.1080/10428194.2025.2539227.
   PubMed        
   
   
9. LAZIC T, Barbieri E, Luminari S
   The emerging role of tafasitamab in follicular lymphoma.
   Leuk Lymphoma. 2025 Oct 15:1-10. doi: 10.1080/10428194.2025.2560083.
   PubMed         Abstract available
   
   
10. HORI Y, Hosoi H, Osuga M, Iwamoto R, et al
    Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA.
    Leuk Lymphoma. 2025 Oct 15:1-11. doi: 10.1080/10428194.2025.2556961.
    PubMed         Abstract available
    
    
11. LU X, Zhao L, Guo S, Chen N, et al
    MiR-22-3p regulates the SIRT1/P53 signaling pathway, thereby influencing ferroptosis in diffuse large B-cell lymphoma cells.
    Leuk Lymphoma. 2025 Oct 15:1-13. doi: 10.1080/10428194.2025.2568186.
    PubMed         Abstract available
    
    
12. HESIUS EAM, Stewart JP, Kroeze LI, van der Spek E, et al
    Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.
    Leuk Lymphoma. 2025 Oct 13:1-14. doi: 10.1080/10428194.2025.2556177.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

13. CORROZA J, Alburquerque C, Martinez-Martinez L, Gaston I, et al
    A single institution series of intravascular lymphoma: Neurological manifestations and neuroimaging findings.
    Neurologia (Engl Ed). 2025;40:768-776.
    PubMed         Abstract available
    
    

    
    Oncology

14. ASANO H, Noguchi Y, Masuda R, Go M, et al
    Sex differences in cardiotoxicity of anaplastic lymphoma kinase inhibitors: An analysis of the FDA Adverse Event Reporting System.
    Oncology. 2025 Oct 13:1-18. doi: 10.1159/000548896.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.